How should a BI-RADS Category 4a breast nodule be managed?
Many people believe that BI-RADS Category 4a breast nodules represent a serious condition. So, how should BI-RADS Category 4a breast nodules be managed?
Management of BI-RADS Category 4a Breast Nodules
Generally, a BI-RADS Category 4a classification suggests a possible malignancy—namely, breast cancer. Management options include short-term observation, pharmacological treatment, and surgical intervention. A detailed analysis follows:
1. Short-Term Observation
A breast nodule is a clinical manifestation characterized by a solid mass in the breast tissue. Based on the development and evolution of breast cysts, breast nodules are classified into six categories according to the BI-RADS system. A Category 4a classification indicates a low to moderate suspicion of malignancy (approximately 2–10% probability of cancer). Patients should promptly visit a reputable hospital for ultrasound-guided core needle biopsy to determine the nature of the lesion. If the nodule is confirmed benign and the patient remains asymptomatic, no immediate intervention is required—close clinical and imaging follow-up is generally sufficient.
2. Pharmacological Treatment
If biopsy confirms a benign nodule but the patient experiences symptoms such as breast tenderness or discomfort, pharmacological therapy may be considered under physician supervision—for example, using Ru Pixiao Granules or Jia Wei Xiao Yao Wan.
3. Surgical Treatment
If the nodule is confirmed malignant, the patient should urgently seek care at a qualified medical center. Surgical management typically involves lumpectomy or mastectomy—including resection of the affected breast tissue and surrounding adipose tissue—as well as sentinel lymph node biopsy or axillary lymph node dissection, aiming to maximize survival duration and preserve quality of life.
Patients are advised to maintain regular daily routines and ensure adequate sleep. We hope this article has been helpful. Wishing you a joyful life and good health!
